List of Tables
Table 1. Global Market Neuroprotection Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Neuroprotection Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Neuroprotection Market Size Share by Region (2018-2023)
Table 4. Global Neuroprotection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Neuroprotection Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Neuroprotection Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Neuroprotection Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Neuroprotection Revenue Market Share by Type (2018-2023)
Table 9. Global Neuroprotection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Neuroprotection Revenue Market Share by Type (2024-2029)
Table 11. North America Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Neuroprotection Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Neuroprotection Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Neuroprotection Revenue Market Share by Application (2018-2023)
Table 24. Global Neuroprotection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Neuroprotection Revenue Market Share by Application (2024-2029)
Table 26. North America Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Neuroprotection Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Neuroprotection Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroprotection as of 2022)
Table 39. Date of Key Players Enter into Neuroprotection Market
Table 40. Global Neuroprotection Key Players Headquarters and Area Served
Table 41. Neuroprotection Product Solution and Service
Table 42. Global Neuroprotection Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. F. Hoffmann-La Roche Basic Information List
Table 45. F. Hoffmann-La Roche Description and Business Overview
Table 46. F. Hoffmann-La Roche Neuroprotection Products, Services and Solutions
Table 47. Revenue (US$ Million) in Neuroprotection Business of F. Hoffmann-La Roche (2018-2023)
Table 48. F. Hoffmann-La Roche Recent Developments
Table 49. Eli Lilly and Company Basic Information List
Table 50. Eli Lilly and Company Description and Business Overview
Table 51. Eli Lilly and Company Neuroprotection Products, Services and Solutions
Table 52. Revenue (US$ Million) in Neuroprotection Business of Eli Lilly and Company (2018-2023)
Table 53. Eli Lilly and Company Recent Developments
Table 54. Daiichi Sankyo Company Basic Information List
Table 55. Daiichi Sankyo Company Description and Business Overview
Table 56. Daiichi Sankyo Company Neuroprotection Products, Services and Solutions
Table 57. Revenue (US$ Million) in Neuroprotection Business of Daiichi Sankyo Company (2018-2023)
Table 58. Daiichi Sankyo Company Recent Developments
Table 59. Allergan Basic Information List
Table 60. Allergan Description and Business Overview
Table 61. Allergan Neuroprotection Products, Services and Solutions
Table 62. Revenue (US$ Million) in Neuroprotection Business of Allergan (2018-2023)
Table 63. Allergan Recent Developments
Table 64. Novartis Basic Information List
Table 65. Novartis Description and Business Overview
Table 66. Novartis Neuroprotection Products, Services and Solutions
Table 67. Revenue (US$ Million) in Neuroprotection Business of Novartis (2018-2023)
Table 68. Novartis Recent Developments
Table 69. AstraZeneca Basic Information List
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Neuroprotection Products, Services and Solutions
Table 72. Revenue (US$ Million) in Neuroprotection Business of AstraZeneca (2018-2023)
Table 73. AstraZeneca Recent Developments
Table 74. Dr. Reddy's Laboratories Basic Information List
Table 75. Dr. Reddy's Laboratories Description and Business Overview
Table 76. Dr. Reddy's Laboratories Neuroprotection Products, Services and Solutions
Table 77. Revenue (US$ Million) in Neuroprotection Business of Dr. Reddy's Laboratories (2018-2023)
Table 78. Dr. Reddy's Laboratories Recent Developments
Table 79. Astrocyte Pharmaceuticals Basic Information List
Table 80. Astrocyte Pharmaceuticals Description and Business Overview
Table 81. Astrocyte Pharmaceuticals Neuroprotection Products, Services and Solutions
Table 82. Revenue (US$ Million) in Neuroprotection Business of Astrocyte Pharmaceuticals (2018-2023)
Table 83. Astrocyte Pharmaceuticals Recent Developments
Table 84. Teva Pharmaceutical Industries Basic Information List
Table 85. Teva Pharmaceutical Industries Description and Business Overview
Table 86. Teva Pharmaceutical Industries Neuroprotection Products, Services and Solutions
Table 87. Revenue (US$ Million) in Neuroprotection Business of Teva Pharmaceutical Industries (2018-2023)
Table 88. Teva Pharmaceutical Industries Recent Developments
Table 89. Biogen Basic Information List
Table 90. Biogen Description and Business Overview
Table 91. Biogen Neuroprotection Products, Services and Solutions
Table 92. Revenue (US$ Million) in Neuroprotection Business of Biogen (2018-2023)
Table 93. Biogen Recent Developments
Table 94. North America Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Neuroprotection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Neuroprotection Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Neuroprotection Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Neuroprotection Market Share by Region (2018-2023)
Table 102. Asia-Pacific Neuroprotection Market Share by Region (2024-2029)
Table 103. Latin America Neuroprotection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Neuroprotection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
Table 109. Neuroprotection Market Trends
Table 110. Neuroprotection Market Drivers
Table 111. Neuroprotection Market Challenges
Table 112. Neuroprotection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroprotection Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Neuroprotection Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Neuroprotection Market Share by Regions: 2022 VS 2029
Figure 4. Global Neuroprotection Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Free Anti-Inflammatory Agents
Figure 11. Global Free Anti-Inflammatory Agents Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Radical Trapping Agents (Antioxidants)
Figure 13. Global Radical Trapping Agents (Antioxidants) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Apoptosis Inhibitors
Figure 15. Global Apoptosis Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Glutamate Antagonists (Anti-Excitotoxic Agents)
Figure 17. Global Glutamate Antagonists (Anti-Excitotoxic Agents) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Neurotrophic Factors (NTFs)
Figure 19. Global Neurotrophic Factors (NTFs) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Product Picture of Stimulants
Figure 21. Global Stimulants Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Product Picture of Metal Ion Chelators
Figure 23. Global Metal Ion Chelators Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Product Picture of Others
Figure 25. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Global Neuroprotection Market Size Share by Type: 2022 & 2029
Figure 27. North America Neuroprotection Revenue Market Share by Type (2018-2029)
Figure 28. Europe Neuroprotection Revenue Market Share by Type (2018-2029)
Figure 29. Asia-Pacific Neuroprotection Revenue Market Share by Type (2018-2029)
Figure 30. Latin America Neuroprotection Revenue Market Share by Type (2018-2029)
Figure 31. Middle East and Africa Neuroprotection Revenue Market Share by Type (2018-2029)
Figure 32. Prevention Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 33. Treatment Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 34. Global Neuroprotection Market Size Share by Application: 2022 & 2029
Figure 35. North America Neuroprotection Revenue Market Share by Application (2018-2029)
Figure 36. Europe Neuroprotection Revenue Market Share by Application (2018-2029)
Figure 37. Asia-Pacific Neuroprotection Revenue Market Share by Application (2018-2029)
Figure 38. Latin America Neuroprotection Revenue Market Share by Application (2018-2029)
Figure 39. Middle East and Africa Neuroprotection Revenue Market Share by Application (2018-2029)
Figure 40. Neuroprotection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 41. Global Top 5 and Top 10 Players Neuroprotection Market Share in 2022
Figure 42. North America Neuroprotection Market Share by Country (2018-2029)
Figure 43. U.S. Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 44. Canada Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 45. Germany Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 46. France Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 47. U.K. Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 48. Italy Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 49. Russia Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 50. Nordic Countries Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 51. Asia-Pacific Neuroprotection Market Share by Region (2018-2029)
Figure 52. China Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 53. Japan Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 54. South Korea Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 55. Southeast Asia Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 56. India Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 57. Australia Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 58. Latin America Neuroprotection Market Share by Country (2018-2029)
Figure 59. Mexico Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 60. Brazil Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 61. Middle East & Africa Neuroprotection Market Share by Country (2018-2029)
Figure 62. Turkey Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 63. Saudi Arabia Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 64. UAE Neuroprotection Market Size (2018-2029) & (US$ Million)
Figure 65. Bottom-up and Top-down Approaches for This Report